Beta-lactamase inhibitors
US10464952B2 · kind B2 · utility
4Cited by
19References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 7, 2018 |
| Grant date | Nov 5, 2019 |
| Priority date | — |
| Expiry date | Jun 7, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2300/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are compounds and compositions that modulate the activity of beta-lactamases. In some embodiments, the compounds described herein inhibit beta-lactamase. In certain embodiments, the compounds described herein are useful in the treatment of bacterial infections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.